Inhibition of Radiographic Progression Across Levels of Composite Index-Defined Disease Activity in Patients With Active Psoriatic Arthritis Treated With Intravenous Golimumab: Results From a Phase-3, Double-Blind, Placebo-Controlled Trial

Arthritis Research & Therapy
doi 10.1186/s13075-020-2126-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial

Arthritis Research & Therapy
2018English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy and Safety of Intravenous Golimumab Through 1 Year in Patients With Active Psoriatic Arthritis

Arthritis Care and Research
Rheumatology
2019English

Radiographic Progression of Structural Joint Damage in Patients With Active Psoriatic Arthritis Treated With Ixekizumab Over 52 Weeks

SKIN The Journal of Cutaneous Medicine
2017English

PMS49 Fatigue Is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients With Rheumatoid Arthritis Treated With Intravenously Administered Golimumab: Results From a Phase 3, Placebo Controlled Clinical Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

A Randomised, Double-Blind, Placebo-Controlled Trial of a Recombinant Version of Human -Fetoprotein (MM-093) in Patients With Active Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

The Effect of Marine N-3 Polyunsaturated Fatty Acids on Cardiac Autonomic and Hemodynamic Function in Patients With Psoriatic Arthritis: A Randomised, Double-Blind, Placebo-Controlled Trial

Artery Research
2016English

Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial

BMC Nephrology
Nephrology
2015English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy